iiinova — where your digital self keeps evolving

Reposted by Adina Turcu

Lauren Fishbein @lmfendo.bsky.social · 16/06/2026

Dr Bill Rainey always presents important and fascinating work on primary aldosteronism. Key points so far: Stain for CYP11B2 on the adrenalectomy tissue and think somatic genetics. #adrenal #PA #ENDO2026 @endocrinesociety.bsky.social

032

Reposted by Adina Turcu

Endocrine Society @endocrinesociety.bsky.social · 16/06/2026

Join MTP39 to explore postoperative adrenal insufficiency and glucocorticoid withdrawal syndrome following surgery for Cushing syndrome. 8:00–8:40 AM | Room W183BC #ENDO2026

011

Reposted by Adina Turcu

Lauren Fishbein @lmfendo.bsky.social · 15/06/2026

Passing the gavel from President Carol Lange to President elect Nanette Santoro at @endocrinesociety.bsky.social #ENDO2026

032

Reposted by Adina Turcu

Lauren Fishbein @lmfendo.bsky.social · 15/06/2026

Let’s learn more about MACS from the esteemed Dr John Newell-Price. #adrenal #ENDO2026 @endocrinesociety.bsky.social

011

Reposted by Adina Turcu

Endocrine Society @endocrinesociety.bsky.social · 13/06/2026

Joe Laakso, PhD, Director of Science Policy, shares why it’s of critical importance to take action and protect NIH Funding research. You can make an impact in 30 seconds by adding your name to the campaign or share your story: bit.ly/2TRULVc #ENDO2026

0153

Reposted by Adina Turcu

Lauren Fishbein @lmfendo.bsky.social · 13/06/2026

Plenary 1: Dr Holly Ingraham speaking on women’s health and genomics. #ENDO2026 @endocrinesociety.bsky.social

052

Reposted by Adina Turcu

Endocrine Society @endocrinesociety.bsky.social · 13/06/2026

Today we honor Robert Carey, MD, MACP, recipient of the Fred Conrad Koch Lifetime Achievement Award—our highest honor recognizing lifetime achievement and exceptional contributions to endocrinology. Read more: bit.ly/46UkZM8 #ENDO2026 #Endocrinology

011

Reposted by Adina Turcu

Journal of Clinical Investigation @jci.org · 06/05/2026

Review: Neuroendocrine and neural control of bone mass in health and disease: doi.org/10.1172/JCI203623 Mone Zaidi et al. discuss the medical consequences arising from dysfunction of two neural pathways regulating bone mass & explore promising therapeutic targets.

021

Reposted by Adina Turcu

Endocrine Society @endocrinesociety.bsky.social · 31/03/2026

Our #FLARE2026 program gathered for two days of professional development and leadership training with our outstanding faculty. During the workshops they received hands-on training in topics ranging from grantsmanship to lab management Learn more: bit.ly/4coX242

042

Reposted by Adina Turcu

The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 30/03/2026

#Endocrine #complications occur in 40–60% of survivors of #cancer and include hypothalamic–pituitary disorders, dysregulation of steroid and peptide hormones, and dysregulation of bone and metabolism thelancet.com/journals/lan... #OpenAccess #MedSky #EndoSky #OncSky

031

Reposted by Adina Turcu

Endocrine Society @endocrinesociety.bsky.social · 27/03/2026

Endocrine Feedback Loop Podcast | Listen to Na Shen, MD, and Kalpana Muthusamy, MD, discuss a recent JCEM article (bit.ly/4rThqyb) on how semaglutide may influence taste perception in women with obesity and polycystic ovary syndrome: bit.ly/EFL071

011

Reposted by Adina Turcu

Endocrine Society @endocrinesociety.bsky.social · 26/03/2026

ENDO 2026: Late-Breaking Abstracts Now Open | Submit your late-breaking abstract for presentation at ENDO by Tuesday, April 21 at 1:00 PM ET: bit.ly/4sF4zAY #ENDO2026 #endocrinology #hormonescience

033

Reposted by Adina Turcu

Endocrine Society @endocrinesociety.bsky.social · 03/03/2026

ESAP 2026: Now Available | Endocrine Self-Assessment (ESAP) 2026 features 120 new, case-based questions developed for endocrinologists who want to sharpen clinical judgment and assess their knowledge with confidence. Order now: bit.ly/40JYQ0d #endocrinology

021

Reposted by Adina Turcu

Endocrine Society @endocrinesociety.bsky.social · 24/02/2026

Nominate yourself for our Rare Endocrine Disease (RED) Fellows Program. Accepted US fellows will receive travel reimbursement for an immersive in-person workshop with leading experts, April 17–18, and access to on-demand courses: bit.ly/4r5S7cD #endocrinology #EndoSky

011

Reposted by Adina Turcu

NEJM.org @nejm.org · 01/12/2025

In a pilot study, a method of imaging in primary aldosteronism was developed with the use of an aldosterone synthase (CYP11B2)–specific ¹⁸F-labeled radioligand for use with positron-emission tomography. Full study results: nej.md/4rypvto #MedSky #EndoSky

Imaging with PET overlaid on CT for participant 17 as a static scan obtained 35 to 45 minutes after administration of the CYP11B2-specific radioligand, which was deemed appropriate for diagnostic imaging.

0102

Reposted by Adina Turcu

NEJM.org @nejm.org · 15/10/2025

BaxHTN phase 3 trial: Aldosterone dysregulation is considered a key driver of hard-to-control hypertension. Research findings on baxdrostat, a highly selective, potent aldosterone synthase inhibitor, in hard-to-control hypertension are summarized in a new Quick Take video. nej.md/3KCsQGJ

A visual representation of the BaxHTN phase 3 trial, which evaluated baxdrostat, a highly selective, potent aldosterone synthase inhibitor, in patients with hard-to-control hypertension.

0125

Reposted by Adina Turcu

European Society of Endocrinology @esendocrinology.bsky.social · 13/10/2025

Following the ESE Executive Committee meeting in Munich last week, members of the ESE leadership team were delighted to be invited to the retirement lecture for Martin Reincke, Past-President of ESE, at @lmumuenchen.bsky.social. We wish Martin all the best in his next chapter. #OurEndocrineCommunity

084

Reposted by Adina Turcu

NEJM.org @nejm.org · 09/10/2025

New in the October 9, 2025, issue of NEJM: Baxdrostat Efficacy and Safety in Uncontrolled Hypertension (BaxHTN phase 3 trial) nej.md/4my7xUZ Nexiguran Ziclumeran in ATTR with Polyneuropathy nej.md/46Qhur7 #MedSky

Images and descriptions of what's new on NEJM.org this week

154

Reposted by Adina Turcu

Endocrine Society @endocrinesociety.bsky.social · 27/09/2025

Endocrine Feedback Loop | Listen to Oksana Hamidi, DO, MSCS, and Jill Wagoner, MD, discuss a recent #JCEM article (bit.ly/4pC3BEl)on mild autonomous cortisol secretion (MACS) is associated with increased risk of vertebral fractures (VFx) (bit.ly/EFL065)

011

Reposted by Adina Turcu

Wanpen Vongpatanasin @drwanpen.bsky.social · 03/09/2025

Got to Baltimore #Hypertension25 so excited to see friends and colleagues talking about high BP ! @ahascience.bsky.social @giaconajohn.bsky.social

0126

Reposted by Adina Turcu

European Journal of Endocrinology @eurojendo.bsky.social · 28/08/2025

A global real-world study assessing total time to adrenalectomy in primary aldosteronism by Charmaine Ter et al EJE Volume 193, Issue 1, July 2025 Open access article 👉 doi.org/10.1093/ejen... #endocrinology #adrenalectomy #aldosteronism

031

Adina Turcu @adinaturcu.bsky.social · 28/08/2025

#ENDO2026 Welcomes Your Ideas | Our annual meeting will take place in Chicago, IL, June 13–16, and I’m inviting YOU to shape the program💡Submit your symposium proposal or session suggestion by Tuesday, September 2: bit.ly/4flCMjl #endocrinology @TheEndoSociety

bit.ly

ENDO 2026 Session Submissions

ENDO wouldn’t be possible without the insight and expertise of the Endocrine community. Your ideas are essential to building a dynamic, forward-thinking program that reflects the full breadth of our f...

055

Reposted by Adina Turcu

Wanpen Vongpatanasin @drwanpen.bsky.social · 20/08/2025

Join us @jordybc.bsky.social , Keith Ferdinand, and Dan Jones unpacking 2025 AHA/ACC guidelines on Thursday Aug 28 bit.ly/Guideline25W... @UTSWInternalMed @utswheart

097

Reposted by Adina Turcu

Endocrine Society @endocrinesociety.bsky.social · 07/08/2025

“Diabetes and Pregnancy” has been long anticipated. For the first time, clinicians will have a definitive guide on treating these patients that now includes the most recent technological breakthroughs in diabetes treatments. Read more in @endocrinenews.bsky.social: bit.ly/45FR4rx #endocrinology

bit.ly

Redefining Diabetes Care in Pregnancy - Endocrine News

New Endocrine Society and European Endocrine Society guidelines provide a much-needed update Making its debut at ENDO 2025, “Diabetes and Pregnancy: An Endocrine Society and European Society of Endocr...

012

Reposted by Adina Turcu

NEJM.org @nejm.org · 06/08/2025

Shalender Bhasin, MB, BS, and Peter J. Snyder, MD, review available data on the benefits and risks of testosterone treatment in middle-aged and older men with moderate hypogonadism. Learn more in a new Review Article: nej.md/4ooeFo7 #MedSky #EndoSky #Urology

Review Article
Testosterone Treatment in Middle-Aged and Older Men with Hypogonadism

An illustrated diagram showing the pathways mediating the physiological and clinical effects of testosterone in men.

032

Reposted by Adina Turcu

Anand Vaidya @anandvaidya17.bsky.social · 15/07/2025

New Primary Aldosteronism Guidelines - simpler, streamlined, and hopefully more pragmatic academic.oup.com/jcem/advance...

0125

Reposted by Adina Turcu

A5_Alliance @a5-adrenal.bsky.social · 15/07/2025

A5 meeting under way in San Francisco, led by our executive chair Dr Habra. #adrenal

041

Reposted by Adina Turcu

Gary D. Hammer, M.D., Ph.D. @garydouglashammer.bsky.social · 15/07/2025

@lmfendo.bsky.social at @endocrinesociety.bsky.social #ENDO2025 presents new data on modifier genes in paraganglioma-pheochromocytoma from GWAS studies with close to 2000 tumor samples from @a5-adrenal.bsky.social teams around the globe. New targets, new biology. Hope for new therapies!

0123

Reposted by Adina Turcu

Endocrine Society @endocrinesociety.bsky.social · 15/07/2025

Editor-in-Chief @zane-andrews.bsky.social will be chairing our #Endocrinology Journal Symposium at 8:00 AM in Room 308 to examine GLP-1-based therapies and the emergence of GLP-1-based multi-agonists combining with other hormones: bit.ly/4lMdrku #ENDO2025 @endosocjournals.bsky.social

bit.ly

ENDO25

031

Reposted by Adina Turcu

Endocrine Society @endocrinesociety.bsky.social · 14/07/2025

Get ready for the third day of ENDO | It was great seeing everyone yesterday for a day full of science! We cannot wait to host you tomorrow. Join us for a wide range of networking events. View our program planner and mark your schedule: bit.ly/4nJotbW

032

Reposted by Adina Turcu

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 14/07/2025

A medical adrenalectomy? ASIs advance - Baxdrostat in primary aldosteronism now www.nejm.org/doi/full/10.... n = 15 single arm trial from @adinaturcu.bsky.social and @astra-zeneca.bsky.social in @nejm.org ~ 25/10 mm Hg BP lowering and impressive aldosterone level drop #Hypertension #EndoSky

02310

Reposted by Adina Turcu

Dr Anastasia S Mihailidou PhD FAHA FCSANZ FESC @anastasiasmihaili.bsky.social · 14/07/2025

Congratulations @adinaturcu.bsky.social & co-authors 👏👏 Exciting time for 🔦 on the equally important second “A” in #RAAS 😁

031

Reposted by Adina Turcu

Gary D. Hammer, M.D., Ph.D. @garydouglashammer.bsky.social · 13/07/2025

Outstanding talk here at @endocrineoncology.bsky.social #ENDO2025 on adrenal Cushing genomics by University of Michigan adrenal team member Juilee Rege here at #ENDO2025. Go Juilee, Go Blue, Go @A5-Alliance

073

Reposted by Adina Turcu

NEJM.org @nejm.org · 13/07/2025

In 15 patients with primary aldosteronism, baxdrostat (a second-generation, nonimidazole aldosterone synthase inhibitor) resolved or reduced the severity of hypertension, excessive aldosterone production, and hypokalemia. Full SPARK study results: nej.md/40Js1kz #ENDO2025

A figure showing the changes from baseline in systolic blood pressure (SBP), plasma aldosterone–renin ratio (ARR), and serum potassium level for each patient.

02915

Reposted by Adina Turcu

European Society of Endocrinology @esendocrinology.bsky.social · 10/07/2025

Join us! ESE Talks...Rare Diseases - CAH; diagnostic and therapeutic challenges across the entire lifespan - A joint webinar with ESE, Endo-ERN and ESPE. 📅 2 September, 17:00-18:30 CEST Register for free 👉 ow.ly/I29350W2XNp #RareDiseases #CAH #Endocrinology

011

Reposted by Adina Turcu

Journal of Clinical Investigation @jci.org · 01/04/2025

Thanks to @UshmaNeill for running the Conversation of Giants in Medicine series for over a decade. Since its inception in 2012, this series has spanned 74 interviews with 80 pioneer scientists: jci.org/videos/cgms Last but not least episode: Video: buff.ly/LF6DMYz Article: jci.org/articles/vie...

buff.ly

JCI’s Conversations with Giants in Medicine: Ending one conversation

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

051